Publication | Open Access
Downregulation of <scp>NCL</scp> attenuates tumor formation and growth in <scp>HeLa</scp> cells by targeting the <scp>PI3K</scp> / <scp>AKT</scp> pathway
15
Citations
29
References
2022
Year
Our findings indicate that downregulation of NCL may be a novel treatment strategy forcervical cancer.
| Year | Citations | |
|---|---|---|
Page 1
Page 1